Skip to content
2000
Volume 18, Issue 3
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Introduction: Flagellate erythema is a distinctive morphologic reaction pattern recognized by whiplash-like pruritic erythematous eruption. It is usually encountered in patients receiving bleomycin. Only one case of docetaxel-induced flagellate erythema is reported in the literature. Case Report: Herein, we report a rare case of docetaxel-induced flagellate erythema in a 53 years old woman with no particular medical history treated with docetaxel for metastatic adenocarcinoma of her right breast. Seven days after the third course, she developed multiple lineal and parallel pruritic erythematous streaks mainly on her chest and abdomen. The cutaneous erythema disappeared gradually over 10 days, leaving hyper-pigmented post-inflammatory linear scars lasting two weeks. The same reaction reappeared after the fourth and the fifth docetaxel course. Conclusion: Flagellate erythema has been reported as an adverse drug reaction secondary to several antineoplastic molecules, including docetaxel. Further studies are needed to discover its underlying mechanisms in order to figure out better treatment plans and prevention.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886317666220613155550
2023-08-01
2025-10-24
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886317666220613155550
Loading

  • Article Type:
    Case Report
Keyword(s): bleomycin; chemotherapy; docetaxel; erythema; Flagellate; pharmacovigilance
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test